POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

Pomdoctor's update details its AI chronic disease management system, which has undergone multiple optimization rounds. This system integrates real-world healthcare data, including medication, diagnosis, patient behavior, monitoring, and payment information. The intent is to use this data to refine AI models, supporting physicians in evaluating health trends and developing personalized management strategies, thereby transitioning towards a more continuous and predictive approach to chronic care.

The company is also progressing with the commercial application of its RWD capabilities. This involves pharmaceutical real-world studies, evidence-based research collaborations, B2B healthcare data services, and partnerships with third-party healthcare institutions. The RWD ecosystem, which includes physiological, medication, behavioral, remote patient monitoring, and insurance-related data, is positioned as a multidimensional foundation for healthcare research and patient management, identified as a core value driver within Pomdoctor's revenue structure.

Additionally, Pomdoctor is advancing integrated in-hospital and out-of-hospital chronic disease management pilots. These pilots, facilitated by its physician service network and digital healthcare infrastructure, aim to extend chronic disease management beyond isolated clinical encounters. The model is designed for ongoing monitoring, physician follow-up, medication management, and personalized intervention, connecting technology capabilities with practical execution in healthcare scenarios.